Time-to-event assessment for the discovery of the proper prognostic value of clinical biomarkers optimized for COVID-19. Clinics, [S. l.], v. 77, p. 100009, 2022. DOI: 10.1016/j.clinsp.2022.100009. Disponível em: https://journals.usp.br/clinics/article/view/213626.. Acesso em: 17 jun. 2024.